Skip to main content
. 2014 Jul 30;29(8):1094–1101. doi: 10.3346/jkms.2014.29.8.1094

Fig. 3.

Fig. 3

Overall survival according to combined modality treatment (A) and use of EGFR-TKI after diagnosis of leptomeningeal metastasis (B) in NSCLC patients.